“…PPGLs have been suggested that are usually associated with 3 syndromes -Von Hippel-Lindau (VHL) syndrome (Hasani-Ranjbar et al 2009), multiple endocrine neoplasia type 2 (MEN 2;Hasani-Ranjbar et al 2011), and neurofi bromatosis type 1 (NF1). Around 40% of PPGLs patients have a germ line mutation in one of the 16 famous susceptibility genes: RET, NF1, VHL, succinate dehydrogenases (SDHA,SDHB,SDHC,SDHD,and SDHAF2),TMEM127,PHD1,PHD2,HIF2A,FH,, and KIF1B (Bayley et al 2010;Majidi et al 2011;Burnichon et al 2012;Darr et al 2012;Galan and Kann 2013;Letouze et al 2013;Castro-Vega et al 2014;Dahia 2014;Welander et al 2014;Yang et al 2015). In fact, there are two separate gene clusters taking part in the tumor genesis of PPGLs according to their transcriptional profi le; kinase receptorsignaling gene cluster (associated with RET/NF1/ TMEM127/MAX/ KIF1B mutations) and a pseudohypoxic gene cluster (associated with mutations in VHL/SDHx/PHD2 genes) (Nolting and Grossman 2012).…”